File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

TitleAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
Authors
Issue Date2017
Citation
The New England Journal of Medicine, 2017, v. 377, p. 122-131 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/312694

 

DC FieldValueLanguage
dc.contributor.authorvon Minckwitz, G-
dc.contributor.authorProcter, M-
dc.contributor.authorde Azambuja, E-
dc.contributor.authorZardavas, D-
dc.contributor.authorBenyunes, M-
dc.contributor.authorKwong, A-
dc.contributor.authorPiccart, M-
dc.contributor.authorBaselga, J-
dc.date.accessioned2022-05-12T10:54:18Z-
dc.date.available2022-05-12T10:54:18Z-
dc.date.issued2017-
dc.identifier.citationThe New England Journal of Medicine, 2017, v. 377, p. 122-131-
dc.identifier.urihttp://hdl.handle.net/10722/312694-
dc.languageeng-
dc.relation.ispartofThe New England Journal of Medicine-
dc.titleAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer-
dc.typeArticle-
dc.identifier.emailKwong, A: avakwong@hku.hk-
dc.identifier.authorityKwong, A=rp01734-
dc.identifier.doi10.1056/NEJMoa1703643-
dc.identifier.hkuros333014-
dc.identifier.volume377-
dc.identifier.spage122-
dc.identifier.epage131-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats